Leinco Technologies, Inc.'s Anti-Human CD276 (B7-H3) (Mirzotamab) - 25 mg monoclonal antibody. The Anti-Human CD276 (B7-H3) (Mirzotamab) - 25 mg Antibody was generated using CD276 as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, Precipitation, ELISA, Flow Cytometry, Functional Assay, Immunoprecipitation, and Western Blot.